EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation

Samuel J Perry, Donal Griffin iD, Eleanor V Williams, Tracy E Roberts, Fong Lien Kwong iD, Sarah Williams, Jon Deeks, Katie Scandrett, Ridhi Agarwal, Sudha S Sundar iD, Mark Monahan

BJOG: An International Journal of Obstetrics & Gynaecology · 2026-03 · 133 (4) · 680-689

DOI: 10.1111/1471-0528.70074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 05.11.2025. Verfasst von Samuel J Perry und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the costs and consequences of seven diagnostic strategies for ovarian cancer in pre‐ and post‐menopausal women with symptoms in secondary care.

Design

Economic evaluation alongside a prospective single‐arm diagnostic accuracy study.

Setting

NHS secondary care outpatients (2‐week referrals, clinics, GP referrals, cross‐specialty referrals) and inpatients (emergency presentations to secondary care). Sample Two cohorts of 857 pre‐menopausal and 1242 post‐menopausal women newly presenting to secondary care with symptoms of suspected ovarian cancer.

Methods

A model‐based cost‐consequence analysis (CCA) was conducted using a decision tree simulating patient pathways over 12 months. Diagnostic accuracy data were sourced from the ROCkeTS study and supplemented by literature. Main Outcome Measures Cancer deaths, correct diagnosis proportion, and diagnostic yield.

Results

No diagnostic strategy was optimal across all outcomes. Across both cohorts, the Risk of Malignancy Index (RMI) 200 was least expensive but had poor cancer death and diagnostic yield outcomes. The ADNEX 3% strategy had the highest diagnostic yield and lowest cancer mortality but was the most expensive. For pre‐menopausal women, the IOTA ADNEX 10% strategy outperformed ORADS, ROMA, and CA125 in cost and outcomes. For post‐menopausal women, the high cancer prevalence required a trade‐off. In sensitivity analysis, a two‐step IOTA ADNEX 10% strategy outperformed ORADS, ROMA, and CA125 across all three outcomes, making the strategy a more balanced choice in both cohorts.

Conclusion

At 12 months, no single diagnostic strategy was superior. Early diagnosis requires balancing cancer mortality, diagnostic yield, and cost. The IOTA ADNEX two‐step strategy at a 10% threshold provided the best trade‐off across these factors and is recommended for practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsEarly Detection of CancerHumansFemaleCost-Benefit AnalysisMiddle AgedProspective StudiesPostmenopauseAgedModels, EconomicPremenopauseReferral and ConsultationAdultSecondary Health CareUnited KingdomCA-125 Antigen

Stichwörter der Autor:innen

cost‐effectivenesseconomic evaluationgynaecologic cancermenopauseultrasound

Substanzen

CA-125 Antigen

Autor:innen und Institutionen

  • Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • University Hospitals Birmingham, Birmingham, UK.
  • NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK.
  • Pan Birmingham Gynaecological Cancer Centre, Midlands Metropolitan University Hospital, Birmingham, UK.

ORCID-Profile: Donal Griffin, Fong Lien Kwong, Sudha S Sundar

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Perry, S. J., Griffin, D., Williams, E. V., Roberts, T. E., Kwong, F. L., Williams, S., Deeks, J., Scandrett, K., Agarwal, R., Sundar, S. S., & Monahan, M. (2026). A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation. BJOG: An International Journal of Obstetrics & Gynaecology, 133(4), 680-689. https://doi.org/10.1111/1471-0528.70074

Vancouver

Perry SJ, Griffin D, Williams EV, Roberts TE, Kwong FL, Williams S, et al. A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation. BJOG: An International Journal of Obstetrics & Gynaecology. 2026;133(4):680-689. doi:10.1111/1471-0528.70074

BibTeX
@article{Perry2026,
  author = {Perry, Samuel J and Griffin, Donal and Williams, Eleanor V and Roberts, Tracy E and Kwong, Fong Lien and Williams, Sarah and Deeks, Jon and Scandrett, Katie and Agarwal, Ridhi and Sundar, Sudha S and Monahan, Mark},
  title = {A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  volume = {133},
  number = {4},
  pages = {680--689},
  doi = {10.1111/1471-0528.70074}
}
Kostenlos starten →